Skip to content
AMPLY Discovery logo — Turning the Dark Genome into Novel Medicines.

AMPLY Discovery

Turning the Dark Genome into Novel Medicines.

Founded 2022 United Kingdom United Kingdom 7 employees Total: $3.66M AI, Biotechnology +2

General Information

Company Name AMPLY Discovery
Founded Year 2022
Location United Kingdom United Kingdom
Employees 7
Industries AI, Biotechnology, Health Care +1
Business Model B2B, SaaS, API
Revenue Model Licensing, Project Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with AMPLY Discovery. To contact AMPLY Discovery, visit amplydiscovery.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AMPLY Discovery compare?

A PDF of AMPLY Discovery and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AMPLY Discovery soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AMPLY Discovery

AMPLY Discovery, established in 2021, is a spin-out from Queen's University Belfast, located in Belfast, Northern Ireland. The company stands at the forefront of innovation with its slogan, "Novel Biologics. Designed by Evolution. Discovered by AI."

Specializing in a unique blend of AI, Biotechnology, Health Care, and Pharmaceutical industries, AMPLY Discovery utilizes cutting-edge machine learning and synthetic biology to excavate extensive biological data. Their proprietary in silico and in vitro hybrid platform aims to identify best-in-class molecules, striving to combat critical challenges like cancer, MDR infections, and metabolic diseases.

Recently, AMPLY Discovery secured an Early VC investment on 01 January 2026 from KPS Inc.. This funding round positions the company well for advancing its ambitious projects, promising potential breakthroughs in biologic drug discovery and nutraceuticals.

Business keywords: Synthetic Biology, Drug Discovery, Nutraceuticals, Biologics, In Silico Platforms, In Vitro Platforms, Cancer Treatment, Metabolic Diseases, MDR Infections, Anti-infectives, Genomics, Metagenomics, Bioinformatics, AI in Healthcare

Services & Products

AI-driven Drug Discovery
Bio-digital Molecular Testing
Application of Evolutionary Biology in Medicine
Virtual Drug Screening

Target Customers

Biopharmaceutical Companies Healthcare Institutions Research Labs Hospitals Government Health Programs

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC Undisclosed 1
KPS Inc.
01 Jan 2026
Seed £1.30M -
01 May 2025
Grant £1.44M 1
Innosuisse
01 Feb 2024
Early VC $20.00K -
01 Aug 2023
Grant £900.00K 1
Clarendon Fund Managers
01 Sep 2022
Spinout Undisclosed 1
University Ventures
01 Jan 2021

AMPLY Discovery Alternatives & Competitors

View All Alternatives
AMPLY Discovery vs
Insilico Medicine
Insilico Medicine United States

#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLMS #AIDD

IPO
286 employees
AI, Biotechnology
AMPLY Discovery vs
Verge Labs
Verge Labs United States

Better drugs, faster. For patients who can’t wait.

Series B
28 employees
Biotechnology, Health Care
AMPLY Discovery vs

Scientific Research by Artificially Intelligent Agents

20 employees
Biotechnology, Pharmaceutical

FAQ About AMPLY Discovery

Turning the Dark Genome into Novel Medicines.
AMPLY Discovery was founded in 2022.
AMPLY Discovery is headquartered in United Kingdom.
AMPLY Discovery operates in AI, Biotechnology, Health Care and Pharmaceutical. Its work centres on Synthetic Biology, Drug Discovery, Nutraceuticals and Biologics. Its customers include Biopharmaceutical Companies, Healthcare Institutions and Research Labs.
AMPLY Discovery has a B2B, SaaS and API business model. Its revenue comes from Licensing, Project Based and Service Fee.
AMPLY Discovery has approximately 7 employees.
AMPLY Discovery has completed 6 funding rounds, raising a total of $3.66M.
AMPLY Discovery offers: AI-driven Drug Discovery, Bio-digital Molecular Testing, Application of Evolutionary Biology in Medicine, Virtual Drug Screening.
Top alternatives and competitors to AMPLY Discovery include Insilico Medicine, Verge Labs, SyntheticGestalt, Arrakis Therapeutics, Hummingbird Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AMPLY Discovery and Insilico Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AMPLY Discovery, https://bouncewatch.com/company/amply-discovery, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout